Securities Litigation (new) — Former underwriter filed breach of contract lawsuit in April 2026 claiming right of first refusal violation on March 2026 offering.
Delisting (removed) — Detailed NYSE American delisting risk disclosure removed after previously disclosing equity deficiency and compliance via alternate standards.

NYSE: MAIA MAIA Biotechnology, Inc. 10-Q

MAIA raises $33M, removes going-concern warning, but faces $2.3M lawsuit over offering

Filed May 11, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 9, 2025 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade MAIA commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 1, 2026 7:36 PM